Skip to content
BidBenchmark

Contract award

REGENERON PHARMACEUTICALS INC

IGF::OT::IGF
PIID
HHSO100201700016C
Award key
CONT_AWD_HHSO100201700016C_7505_-NONE-_-NONE-
Recipient UEI
N3F9MH7E6HD6
Source as of
Current award value
$695,741,4763
Obligated to date
$695,741,4762
Potential with options
$759,103,2243
Awarding agency
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response
Place of performance
Tarrytown, New York
Set-aside
No set-aside used
Pricing
Cost Plus Fixed Fee
Competition
Full and Open Competition2 offers received
Period of performance
Sep 30, 2017Sep 29, 2027Through Sep 29, 2027 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Sep 28, 2017Initial award$40,444,612.00$695,741,475.58
1Feb 13, 2018G$27,653,801.00$695,741,475.58
2May 9, 2018G$25,896,179.00$695,741,475.58
3Aug 13, 2018M$52,635,588.00$695,741,475.58
P00004May 22, 2019G$131,811,954.00$695,741,475.58
P00005Sep 25, 2019M$22,824,429.67$695,741,475.58
P00006Apr 23, 2020B$47,277,219.00$695,741,475.58
P00007May 6, 2020M-$67,856.00$695,741,475.58
P00008Jul 25, 2020G$344,581,000.00$695,741,475.58
P00009Apr 20, 2021M$0.00$695,741,475.58
P00010Jul 29, 2021D$0.00$695,741,475.58
P00011Sep 29, 2022B$0.00$695,741,475.58
P00013Dec 14, 2022D$0.00$695,741,475.58
P00014Nov 7, 2023M$0.00$695,741,475.58
P00015Dec 6, 2024D$0.00$695,741,475.58
P00016Aug 6, 2025D$0.00$695,741,475.58
P00017Jul 30, 2026D$2,684,548.91$695,741,475.58

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.22a0811187e9e
contractor_idUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.22a0811187e9e
current_award_valueUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.22a0811187e9e
naics_codeUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.22a0811187e9e
potential_award_valueUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.22a0811187e9e
psc_codeUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.22a0811187e9e
total_obligatedUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.22a0811187e9e

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 17 transaction records parsed from USAspending.gov, retrieved Aug 10, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
HHSO100201700016C — REGENERON PHARMACEUTICALS INC · BidBenchmark